Investigation of the role of clonal haematopoiesis as a susceptibility factor in COVID-19 infection – CHIP-COVID-19
COVID-19 disease has been labelled a pandemic by WHO. Although old people are more susceptible, younger people can also succumb to the illness and we currently do not know who is at high risk. Understanding what makes people susceptible can help protect the vulnerable and guide the choice/development of treatments. Unbeknown to them, many people harbour abnormal blood cells in their body as a result of random gene changes that happen with time. Such cells react abnormally to inflammation leading to many illnesses. Here, we want to test if these cells are responsible for severe COVID-19 disease.
Project coordination
Ziad MALLAT (INSERM U970 - PARCC)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
University of Cambridge
PARCC INSERM U970 - PARCC
Help of the ANR 59,000 euros
Beginning and duration of the scientific project:
June 2020
- 6 Months
